Last Posted: Jan 22, 2020
- APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.
Gudsoorkar Prakash et al. American journal of nephrology 2020 Jan 1-3 - Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology.
de Haan Amber et al. Frontiers in genetics 2019 101264 - Fabry Disease Prevalence in Renal Replacement Therapy in Turkey.
Yalin Serkan Feyyaz et al. Nephron 2019 142(1) 26-33 - The Characteristics of Patients with Possible Familial Hypercholesterolemia- Screening a Large Payer/ProviderHealthcare Delivery System.
Elis A et al. QJM : monthly journal of the Association of Physicians 2019 Dec - Variation of ApoL1 Testing Practices for Living Kidney Donors.
McIntosh Tristan et al. Progress in transplantation (Aliso Viejo, Calif.) 2019 Dec 1526924819892917 - Frequency of ClinVar Pathogenic Variants in Chronic Kidney Disease Patients Surveyed for Return of Research Results at a Cleveland Public Hospital.
Crawford Dana C et al. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2020 25575-586 - Methods for algorithmic diagnosis of metabolic syndrome.
Vrbaški Dunja et al. Artificial intelligence in medicine 2019 Nov 101101708 - Alport Syndrome in Women and Girls.
Savige Judy et al. Clinical journal of the American Society of Nephrology : CJASN 2016 11(9) 1713-20 - Predicting Risk of Kidney Disease: Is Risk-Based Kidney Care on the Horizon?
SL Tummalapalli et al, JAMA, November 8, 2019 - Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.
Neugut Y Dana et al. Annals of internal medicine 2019 Oct
.png)
No hay comentarios:
Publicar un comentario